Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marine Ingredients is a leading provider of marine-based nutritional ingredients, specializing in high-quality omega-3 fatty acids derived from fish oil. The company offers a broad range of products including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) concentrates, cod liver oil, and customized lipid blends. Following its acquisition by the KD Pharma Group in 2016, Marine Ingredients integrated its sourcing and product development expertise with KD Pharma's advanced purification technologies. The company provides end-to-end solutions from raw material sourcing to finished product manufacturing, including softgel encapsulation and liquid bottling. Its products serve the dietary supplement, functional food, and pharmaceutical industries globally. Marine Ingredients is recognized for its commitment to sustainability and high-purity standards in the marine lipid market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marine Ingredients.